Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy 癌症病人PSA前列腺治疗变形价值水ADT摘要:doi:10.4103/aja.aja_24_18Yasutaka YamadaDepartment of UrologyHiroomi NakatsuDepartment of UrologyShinichi SakamotoDepartment of UrologyYoshiyasu ...
Among men with elevated prostate-specific antigen (PSA) but no CaP, the mortality rates were slightly lower, and fewer differences in comorbidities and medication use were noted compared to men without elevated PSA. Many prevalent comorbidities and medications were consistent across groups and are ...
Between January 2007 and May 2011, 669 patients (mean 64 years; range 38–91 years) underwent a re-biopsy because of previous negative biopsy (median 1; 1–5) and persistently high prostate-specific antigen (PSA 10.6 ng/ml; 2.5–997.1 ng/ml). 3T MRI using a phased-array coil was perf...
Univariate logistic regression analysis indicated that older age, higher PSA levels, lower f/tPSA ratio, smaller prostate volume, and higher PSAD were all significantly associated with csPCa on biopsy (Fig. 2A). These findings suggest that these characteristics may serve as potential predictive facto...
B, Decision curve analysis plots illustrating the net reduction in biopsies performed per 100 patients without missing a single diagnosis of cancer of grade group 2 or greater based on prebiopsy testing with PSA alone, the Prostate Cancer Prevention Trial risk calculator, PHI, the derived multiplex...
Objective High-dose-rate (HDR) brachytherapy boost represents a method to dose escalate in high-risk prostate cancer; the purpose of this analysis is to report long-term outcomes for a group of high-risk patients with Gleason 8 through 10 prostate cancer treated with HDR brachytherapy boost from...
1 In 2012, the US Preventive Services Task Force recommended against routine prostate-specific antigen (PSA) screening owing to risk of overdiagnosis of clinically insignificant prostate cancer. Consequently, there has been a decrease in indolent, localized disease, but a concordant increase of ...
B47 - The role of PSA for prostate cancer detection in patients with high grade intraepithelial neoplasia 来自 Semantic Scholar 喜欢 0 阅读量: 25 作者:D.,Milonas,G.,Skulcius,S.,Auskalnis,I.,Gudinaviciene,M.,Jievaltas 摘要: Lung volume, airway resistance, and compliance have been measured...
1 In 2012, the US Preventive Services Task Force recommended against routine prostate-specific antigen (PSA) screening owing to risk of overdiagnosis of clinically insignificant prostate cancer. Consequently, there has been a decrease in indolent, localized disease, but a concordant increase of ...
These findings suggest that high serum levels of CEA and CA19-9 in patients with prostate cancer are indications of hormone-refractory prostate cancer ... Y Kinebuchi,W Noguchi,K Irie,... 被引量: 0发表: 2007年 High Stage Prostate Cancer with Low Serum PSA Level: A Case Report Serum pro...